Depressive symptoms in individuals diagnosed with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH) in middle-aged and older Chinese individuals: Results from the China Health and Retirement Longitudinal Study
- PMID: 34565588
- DOI: 10.1016/j.jad.2021.09.045
Depressive symptoms in individuals diagnosed with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH) in middle-aged and older Chinese individuals: Results from the China Health and Retirement Longitudinal Study
Abstract
Objectives: Male lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH) is common and may increase the risk of depressive symptoms. This study aimed to investigate the associated factors of LUTS/BPH and its association with depressive symptoms in middle-aged and older Chinese men.
Methods: This study used data from the 2015 China Health and Retirement Longitudinal Study (CHARLS). A total number of 8,586 men aged ≥45 years were included in this study. Participants answered positively to whether they have ever been diagnosed with a prostate illness (excluding prostatic cancer) were defined as LUTS/BPH individuals. Depressive symptoms were assessed using the 10-item Center for Epidemiological Studies Depression Scale (CESD-10). Multivariate logistic analyses were applied to explore the associated factors of LUTS/BPH, association between LUTS/BPH and depressive symptoms, and risk factors of depressive symptoms according to LUTS/BPH status.
Results: The weighted overall prevalence of LUTS/BPH was 13.1% in Chinese men aged ≥45 years. The prevalence of depressive symptoms was 29.1% in LUTS/BPH individuals and 22.9% in non-LUTS/BPH individuals. Depressive symptoms and LUTS/BPH shared some same risk factors, which were education, living regions, annual household consumption, sleep duration and multimorbidity. The results from logistic models showed that education, sleep duration and multimorbidity were significantly and independently associated with depression of LUTS/BPH individuals (P<0.001).
Conclusions: Prevalence of depressive symptoms in LUTS/BPH population was higher than in non-LUTS/BPH population. Education, sleep duration and multimorbidity were associated with the onset of depressive symptoms in LUTS/BPH individuals (P<0.001).
Keywords: CHARLS; Chinses; LUTS/BPH; depressive symptoms; middle-aged and older adults.
Copyright © 2021. Published by Elsevier B.V.
Similar articles
-
Prevalence of lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH) in China: results from the China Health and Retirement Longitudinal Study.BMJ Open. 2019 Jun 19;9(6):e022792. doi: 10.1136/bmjopen-2018-022792. BMJ Open. 2019. PMID: 31221864 Free PMC article.
-
Depressive males have higher odds of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a retrospective cohort study based on propensity score matching.Asian J Androl. 2021 Nov-Dec;23(6):633-639. doi: 10.4103/aja.aja_12_21. Asian J Androl. 2021. PMID: 33818525 Free PMC article.
-
The prevalence and associated factors of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in aging males.Aging Male. 2020 Dec;23(5):1432-1439. doi: 10.1080/13685538.2020.1781806. Epub 2020 Jun 25. Aging Male. 2020. PMID: 32583703
-
Burden of male lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) - focus on the UK.BJU Int. 2015 Apr;115(4):508-19. doi: 10.1111/bju.12745. Epub 2014 Oct 16. BJU Int. 2015. PMID: 24656222 Review.
-
The Epidemiology of Benign Prostatic Hyperplasia Associated with Lower Urinary Tract Symptoms: Prevalence and Incident Rates.Urol Clin North Am. 2016 Aug;43(3):289-97. doi: 10.1016/j.ucl.2016.04.001. Urol Clin North Am. 2016. PMID: 27476122 Review.
Cited by
-
Lower Urinary Tract Symptoms in Depression: A Review.Health Psychol Res. 2023 Jul 15;11:81040. doi: 10.52965/001c.81040. eCollection 2023. Health Psychol Res. 2023. PMID: 37465591 Free PMC article.
-
Combination of Lycopene and Curcumin Synergistically Alleviates Testosterone-Propionate-Induced Benign Prostatic Hyperplasia in Sprague Dawley Rats via Modulating Inflammation and Proliferation.Molecules. 2023 Jun 21;28(13):4900. doi: 10.3390/molecules28134900. Molecules. 2023. PMID: 37446563 Free PMC article.
-
Suicidal risk associated with finasteride versus dutasteride among men treated for benign prostatic hyperplasia: nationwide cohort study.Sci Rep. 2023 Mar 31;13(1):5308. doi: 10.1038/s41598-023-32356-3. Sci Rep. 2023. PMID: 37002313 Free PMC article.
-
Sodium butyrate treatment and fecal microbiota transplantation provide relief from ulcerative colitis-induced prostate enlargement.Front Cell Infect Microbiol. 2022 Oct 25;12:1037279. doi: 10.3389/fcimb.2022.1037279. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 36389141 Free PMC article.
-
Association of sleep quality with lower urinary tract symptoms/benign prostatic hyperplasia among men in China: A cross-sectional study.Front Aging Neurosci. 2022 Oct 24;14:938407. doi: 10.3389/fnagi.2022.938407. eCollection 2022. Front Aging Neurosci. 2022. PMID: 36353690 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
